| Name | Title | Contact Details |
|---|
Surgalign Holdings, Inc. is a global medical technology company committed to the promise of digital health to drive transformation across the surgical landscape. Uniquely aligned and resourced to advance the standard of care, the company is building technologies physicians and other health providers will look to for what is truly possible for their patients. Surgalign is focused on developing solutions that predictably deliver superior clinical and economic outcomes. Surgalign markets products throughout the United States and in approximately 50 countries worldwide through an expanding network of top independent distributors. Surgalign is headquartered in Deerfield, IL, with commercial, innovation and design centers in San Diego, CA, Warsaw and Poznan, Poland and Wurmlingen, Germany.
AccessOne is a leading provider of flexible, co-branded patient financing solutions. Founded by providers, our solution provides a consumer-focused experience which drives high patient satisfaction for our clients. We have helped over one million consumers afford out-of-pocket medical expenses for health systems nationwide. We offer the most comprehensive platform in the industry with funding models that help more providers and programs that reach more patients. All patients qualify for our program with no credit reporting or negative outcomes.
Clinicon Corporation is a Oceanside, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Silk Road Medical, Inc. is a medical device company located in Sunnyvale, California, that is focused on reducing the risk of stroke and its devastating impact. The company has pioneered a new approach for the treatment of carotid artery disease called TransCarotid Artery Revascularization (TCAR). TCAR is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke. The TransCarotid Artery Revascularization (TCAR) Procedure is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke. The ENROUTE® Transcarotid Neuroprotection and Stent System are the first and only products specifically designed and indicated for TCAR in high surgical risk patients that need carotid intervention.
American Oncology Network, LLC (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success of community oncology. With more than three decades of expertise in all areas of oncology practice management, AON enables physicians to focus on what matters most – providing the highest quality care for patients. We preserve and protect the sustainability of community oncology for physicians, patients and partners, so practices thrive. Ensure that every American has local access to exceptional cancer care. AON provides comprehensive administrative support and ancillary services that help community oncology practices thrive in an increasingly complex healthcare environment. Our collaborative approach and physician-led model allows practices to maintain local leadership and autonomy. With over three decades of successfully improving and advancing community oncology practices, we have developed a proven business model that allows practices to benefit from our scale and expertise in such critical areas as drug-procurement and payer contracting, as well as practice diversification through central lab and pathology, specialty pharmacy. AON was created and is led by the leadership team responsible for the success of Florida Cancer Specialists & Research Institute, the nation`s largest independent community oncology practice. Our team has vast experience in complex and diverse group practice integration and is able to ensure a smooth and successful transition process for local practices that choose to become a part of the AON.